Cargando…

To treat or not to treat asymptomatic hyperuricemia in chronic kidney disease

Detalles Bibliográficos
Autor principal:	Shin, Dong Ho
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society of Nephrology 2019
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6727889/ https://www.ncbi.nlm.nih.gov/pubmed/31474091 http://dx.doi.org/10.23876/j.krcp.19.074

Ejemplares similares

Hyperuricemia and chronic kidney disease: to treat or not to treat
por: Piani, Federica, et al.
Publicado: (2021)

Hyperuricemia, the heart, and the kidneys – to treat or not to treat?
por: Petreski, Tadej, et al.
Publicado: (2020)

Role of asymptomatic hyperuricemia in the progression of chronic kidney disease and cardiovascular disease
por: Waheed, Yousuf, et al.
Publicado: (2021)

The grey zone of Hyperuricemia in chronic kidney disease
por: Dousdampanis, Periklis
Publicado: (2017)

Urate-lowering agents for asymptomatic hyperuricemia in stage 3 – 4 chronic kidney disease: Controversial role of kidney function
por: Jeon, Hee Jung, et al.
Publicado: (2019)

Physicians’ perceptions of asymptomatic hyperuricemia in patients with chronic kidney disease: A questionnaire survey
por: Cha, Ran-hui, et al.
Publicado: (2019)

Asymptomatic hyperuricemia and chronic kidney disease: Narrative review of a treatment controversial
por: Eleftheriadis, Theodoros, et al.
Publicado: (2017)

Acupuncture to treat asymptomatic hyperuricemia: A protocol for systematic review and meta-analysis of randomized controlled trials
por: Hwang, Ji Hye, et al.
Publicado: (2021)

Hyperuricemia: A non-traditional risk factor for development and progression of chronic kidney disease?
por: Kang, Duk-Hee
Publicado: (2012)

Treatment of asymptomatic hyperuricemia in chronic kidney disease: A new target in an old enemy – A review
por: Ramirez, Maria Erika G., et al.
Publicado: (2017)

Prevention of Renal Damage by Treating Hyperuricemia
por: Nickavar, Azar
Publicado: (2013)

The Consequences of Treating Asymptomatic Malaria Parasitemia
por: White, Nicholas J.
Publicado: (2017)

Febuxostat for Hyperuricemia in Patients with Advanced Chronic Kidney Disease
por: Akimoto, Tetsu, et al.
Publicado: (2014)

Cost of treating diabetic kidney disease
por: Dasgupta, I.
Publicado: (2014)

Comment on: Prevention of Renal Damage by Treating Hyperuricemia
por: Nasri, Hamid, et al.
Publicado: (2015)

Pro: should asymptomatic patients with moderate-to-severe OSA be treated?
por: Ryan, Silke
Publicado: (2019)

Con: should asymptomatic patients with moderate-to-severe  OSA be treated?
por: Vakulin, Andrew, et al.
Publicado: (2019)

Efficacy and safety of febuxostat for treating hyperuricemia in patients with chronic kidney disease and in renal transplant recipients: A systematic review and meta-analysis
por: Liu, Xuzhong, et al.
Publicado: (2018)

Associations Between Hyperuricemia and Chronic Kidney Disease: A Review
por: Prasad Sah, Om Shankar, et al.
Publicado: (2015)

Joint association of hyperuricemia and chronic kidney disease with mortality in patients with chronic heart failure
por: Wang, Chi, et al.
Publicado: (2023)

Asymptomatic hyperuricemia and coronary artery disease in elderly patients without comorbidities
por: Wu, Junnan, et al.
Publicado: (2017)

Association between asymptomatic hyperuricemia and new-onset chronic kidney disease in Japanese male workers: a long-term retrospective cohort study
por: Kawashima, Masatoshi, et al.
Publicado: (2011)

Relationship between oxidative stress and inflammation in hyperuricemia: Analysis based on asymptomatic young patients with primary hyperuricemia
por: Zhou, You, et al.
Publicado: (2018)

Treating Hyperuricemia: The Last Word Hasn’t Been Said Yet
por: Russo, Elisa, et al.
Publicado: (2021)

Psoriatic arthritis with hyperuricemia: more peripheral, destructive, and challenging to treat
por: Widawski, L., et al.
Publicado: (2022)

Management of Hyperuricemia in Patients with Chronic Kidney Disease: a Focus on Renal Protection
por: Kielstein, Jan T., et al.
Publicado: (2020)

Traditional Chinese herbs and natural products in hyperuricemia-induced chronic kidney disease
por: Yang, Letian, et al.
Publicado: (2022)

Association between Dietary Fat Intake and Hyperuricemia in Men with Chronic Kidney Disease
por: Oku, Fumika, et al.
Publicado: (2022)

Allopurinol for prevention of progression of kidney disease with hyperuricemia
por: Pai, B. H. Santhosh, et al.
Publicado: (2013)

Hyperuricemia Is Associated with Left Ventricular Dysfunction and Inappropriate Left Ventricular Mass in Chronic Kidney Disease
por: Chiu, Tai-Hua, et al.
Publicado: (2020)

Asymptomatic hyperuricemia and coronary flow reserve in patients with metabolic syndrome
por: Kim, Seoyoung C., et al.
Publicado: (2018)

Gut Microbiota Characterization in Patients with Asymptomatic Hyperuricemia: probiotics increased
por: Yang, Hai-Tao, et al.
Publicado: (2021)

Asymptomatic bacteriuria in recurrent UTI – to treat or not to treat
por: Cai, Tommaso, et al.
Publicado: (2017)

Alleviation of Hyperuricemia by Strictinin in AML12 Mouse Hepatocytes Treated with Xanthine and in Mice Treated with Potassium Oxonate
por: Huang, Kuo-Ching, et al.
Publicado: (2023)

Hyperuricemia and uncontrolled hypertension in treated hypertensive patients: K-MetS Study
por: Cho, Jaelim, et al.
Publicado: (2016)

Mechanisms Linking Hyperuricemia to Increased Cardiovascular Risk
por: Kang, Eun Ha
Publicado: (2019)

Determinants of hyperuricemia in non-dialysed chronic kidney disease patients in three hospitals in Cameroon
por: Doualla, Marie, et al.
Publicado: (2018)

Different clinical impact of hyperuricemia according to etiologies of chronic kidney disease: Gonryo Study
por: Watanabe, Kimio, et al.
Publicado: (2021)

Hyperuricemia and Associated Factors in Children with Chronic Kidney Disease: A Cross-Sectional Study
por: Xu, Jie, et al.
Publicado: (2021)

Vegan Diet Is Associated with a Lower Risk of Chronic Kidney Disease in Patients with Hyperuricemia
por: Wu, Chia-Lin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_upgp2sutuue5dr0cqd3uc3c5vi